Group One Trading
CGEM icon

Group One Trading’s Cullinan Oncology CGEM Stock Holding History

Group One Trading’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Buy
10,763
+1,907
+22% +$28.3K ﹤0.01% 4304
2026
Q1 		$126K Buy
+8,856
New +$114K ﹤0.01% 4518
2025
Q2 		– Sell
-389
Closed -$3.13K – 7993
2025
Q1 		$2.94K Buy
389
+373
+2,331% +$3.58K ﹤0.01% 6857
2024
Q4 		$195 Buy
+16
New +$230 ﹤0.01% 7067
2024
Q3 		– Sell
-14
Closed -$248 – 6706
2024
Q2 		$244 Hold
14
– – ﹤0.01% 6511
2024
Q1 		$239 Buy
+14
New +$216 ﹤0.01% 6796
2023
Q4 		– Sell
-43,182
Closed -$383K – 7456
2023
Q3 		$391K Buy
+43,182
New +$450K ﹤0.01% 3163
2022
Q2 		– Sell
-100
Closed -$1.13K – 7881
2022
Q1 		$1K Buy
+100
New +$1.35K ﹤0.01% 7810

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Group One Trading's CGEM Position: Q2 2026 in Review

Group One Trading increased its Cullinan Oncology (CGEM) stake by 22% in Q2 2026, buying an estimated $28.3K and bringing the position to 10,763 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #4304.

Group One Trading first reported a position in CGEM in Q1 2022 and has held it in 8 quarters since. The position peaked at $391K in Q3 2023. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Group One Trading held 10,763 shares of Cullinan Oncology worth $196K as of Q2 2026.
  • Group One Trading bought 1,907 Cullinan Oncology shares in Q2 2026, an estimated $28.3K.
  • Cullinan Oncology made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4304 holding.
  • Group One Trading first reported a position in Cullinan Oncology in Q1 2022 and has held it in 8 quarters since.
  • Group One Trading's Cullinan Oncology position peaked at $391K in Q3 2023.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.